node1 | node2 | node1 accession | node2 accession | node1 annotation | node2 annotation | score |
AFK07289.1 | AFK07290.1 | Theba_1625 | Theba_1626 | Hypothetical protein. | Putative phosphatase, C-terminal domain of histone macro H2A1 like protein; PFAM: Macro domain. | 0.551 |
AFK07289.1 | AFK07291.1 | Theba_1625 | Theba_1627 | Hypothetical protein. | Hypothetical protein. | 0.551 |
AFK07290.1 | AFK07289.1 | Theba_1626 | Theba_1625 | Putative phosphatase, C-terminal domain of histone macro H2A1 like protein; PFAM: Macro domain. | Hypothetical protein. | 0.551 |
AFK07290.1 | AFK07291.1 | Theba_1626 | Theba_1627 | Putative phosphatase, C-terminal domain of histone macro H2A1 like protein; PFAM: Macro domain. | Hypothetical protein. | 0.773 |
AFK07290.1 | AFK07292.1 | Theba_1626 | Theba_1628 | Putative phosphatase, C-terminal domain of histone macro H2A1 like protein; PFAM: Macro domain. | DNA-directed RNA polymerase, beta subunit/140 kD subunit; PFAM: RNA polymerase Rpb1, domain 2; RNA polymerase Rpb2, domain 6; RNA polymerase Rpb1, domain 5. | 0.567 |
AFK07290.1 | AFK07293.1 | Theba_1626 | Theba_1629 | Putative phosphatase, C-terminal domain of histone macro H2A1 like protein; PFAM: Macro domain. | Hypothetical protein. | 0.533 |
AFK07290.1 | AFK07294.1 | Theba_1626 | Theba_1630 | Putative phosphatase, C-terminal domain of histone macro H2A1 like protein; PFAM: Macro domain. | Transcriptional regulator containing GAF, AAA-type ATPase, and DNA binding domains; PFAM: Sigma-54 interaction domain. | 0.533 |
AFK07290.1 | AFK07295.1 | Theba_1626 | Theba_1631 | Putative phosphatase, C-terminal domain of histone macro H2A1 like protein; PFAM: Macro domain. | CRISPR-associated endoribonuclease Cas6; CRISPR (clustered regularly interspaced short palindromic repeat), is an adaptive immune system that provides protection against mobile genetic elements (viruses, transposable elements and conjugative plasmids). CRISPR clusters contain sequences complementary to antecedent mobile elements and target invading nucleic acids. CRISPR clusters are transcribed and processed into CRISPR RNA (crRNA). | 0.502 |
AFK07291.1 | AFK07289.1 | Theba_1627 | Theba_1625 | Hypothetical protein. | Hypothetical protein. | 0.551 |
AFK07291.1 | AFK07290.1 | Theba_1627 | Theba_1626 | Hypothetical protein. | Putative phosphatase, C-terminal domain of histone macro H2A1 like protein; PFAM: Macro domain. | 0.773 |
AFK07291.1 | AFK07292.1 | Theba_1627 | Theba_1628 | Hypothetical protein. | DNA-directed RNA polymerase, beta subunit/140 kD subunit; PFAM: RNA polymerase Rpb1, domain 2; RNA polymerase Rpb2, domain 6; RNA polymerase Rpb1, domain 5. | 0.533 |
AFK07291.1 | AFK07293.1 | Theba_1627 | Theba_1629 | Hypothetical protein. | Hypothetical protein. | 0.533 |
AFK07291.1 | AFK07294.1 | Theba_1627 | Theba_1630 | Hypothetical protein. | Transcriptional regulator containing GAF, AAA-type ATPase, and DNA binding domains; PFAM: Sigma-54 interaction domain. | 0.533 |
AFK07291.1 | AFK07295.1 | Theba_1627 | Theba_1631 | Hypothetical protein. | CRISPR-associated endoribonuclease Cas6; CRISPR (clustered regularly interspaced short palindromic repeat), is an adaptive immune system that provides protection against mobile genetic elements (viruses, transposable elements and conjugative plasmids). CRISPR clusters contain sequences complementary to antecedent mobile elements and target invading nucleic acids. CRISPR clusters are transcribed and processed into CRISPR RNA (crRNA). | 0.502 |
AFK07292.1 | AFK07290.1 | Theba_1628 | Theba_1626 | DNA-directed RNA polymerase, beta subunit/140 kD subunit; PFAM: RNA polymerase Rpb1, domain 2; RNA polymerase Rpb2, domain 6; RNA polymerase Rpb1, domain 5. | Putative phosphatase, C-terminal domain of histone macro H2A1 like protein; PFAM: Macro domain. | 0.567 |
AFK07292.1 | AFK07291.1 | Theba_1628 | Theba_1627 | DNA-directed RNA polymerase, beta subunit/140 kD subunit; PFAM: RNA polymerase Rpb1, domain 2; RNA polymerase Rpb2, domain 6; RNA polymerase Rpb1, domain 5. | Hypothetical protein. | 0.533 |
AFK07292.1 | AFK07293.1 | Theba_1628 | Theba_1629 | DNA-directed RNA polymerase, beta subunit/140 kD subunit; PFAM: RNA polymerase Rpb1, domain 2; RNA polymerase Rpb2, domain 6; RNA polymerase Rpb1, domain 5. | Hypothetical protein. | 0.774 |
AFK07292.1 | AFK07294.1 | Theba_1628 | Theba_1630 | DNA-directed RNA polymerase, beta subunit/140 kD subunit; PFAM: RNA polymerase Rpb1, domain 2; RNA polymerase Rpb2, domain 6; RNA polymerase Rpb1, domain 5. | Transcriptional regulator containing GAF, AAA-type ATPase, and DNA binding domains; PFAM: Sigma-54 interaction domain. | 0.785 |
AFK07292.1 | AFK07295.1 | Theba_1628 | Theba_1631 | DNA-directed RNA polymerase, beta subunit/140 kD subunit; PFAM: RNA polymerase Rpb1, domain 2; RNA polymerase Rpb2, domain 6; RNA polymerase Rpb1, domain 5. | CRISPR-associated endoribonuclease Cas6; CRISPR (clustered regularly interspaced short palindromic repeat), is an adaptive immune system that provides protection against mobile genetic elements (viruses, transposable elements and conjugative plasmids). CRISPR clusters contain sequences complementary to antecedent mobile elements and target invading nucleic acids. CRISPR clusters are transcribed and processed into CRISPR RNA (crRNA). | 0.723 |
AFK07293.1 | AFK07290.1 | Theba_1629 | Theba_1626 | Hypothetical protein. | Putative phosphatase, C-terminal domain of histone macro H2A1 like protein; PFAM: Macro domain. | 0.533 |